High-performance liquid chromatographic determination of acrolein as a marker for cyclophosphamide bioactivation in human liver microsomes
- 1 April 1997
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 692 (1) , 163-168
- https://doi.org/10.1016/s0378-4347(96)00457-4
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Ifosfamide stereoselective dichloroethylation and neurotoxicityThe Lancet, 1994
- Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamideBiochemical Pharmacology, 1994
- Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapyCancer Chemotherapy and Pharmacology, 1993
- Determination of Acrolein in Urine by Liquid Chromatography and Fluorescence Detection of Its Quinoline DerivativePharmaceutical Research, 1993
- High-performance liquid chromatographic method for quantitation of acrolein in biological samplesJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- DECHLOROETHYLATION OF IFOSFAMIDE AND NEUROTOXICITYThe Lancet, 1986
- Fluorometric determination of 4-hydroxyifosfamide in blood and urine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidationGastroenterology, 1983
- Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamideBiochemical Pharmacology, 1974
- Fluorometric determination of acrolein and related compounds with m-aminophenolAnalytical Chemistry, 1968